Preventing HIV as core business. Debbie Muirhead Andrew Van Zyl Aurum Institute for Health Research. Outline of presentation. The treatment take over Economics of HIV prevention Why a prevention focus should be at the core of our business HIV response - costs
Andrew Van Zyl
Aurum Institute for Health Research
The TREATMENT TAKEOVER
Trial based research
Pilot community projects
Private sector roll out
Government roll out
The Value of Preventing New Infections
Costs are inflated into the future and then discounted. The above represents an example of one category of worker in one company
Behavioural change communication
Counselling & Testing
Barrier methods (Male & Female Condoms)
CERVICAL BARRIERS (Vaginal Diaphragms)
BARRIER METHODS (Male & Female Condoms)
Ref: *Tsai C-C, et al. Science 1995: 270:1197-1199; **Veazey RS et al.
Auvert B, Taljaard D, Lagarde E et al (2005) Randomized controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Medicine 2:e298
Bailey RC, Moses S, Parker CB et al (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet; 369 pp 643-56.
Christofides N, Muirhead D, Jewkes R et al (2006) Inlcuding post-exposure prophylaxis to prevent HIV/AIDS into post sexual assualt health services in South Africa: Costs and cost effectiveness of user preferred approaches to provision. Report to DoH & Unicef (accessed on SA MRC website)
Corbett E, Makamure B, Cheung Y et al (2007) HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS; 21; pp 483-389
Corbett E, Dauya E, Matambo R (2006) Uptake of Workplace HIV counselling and Testing: A Cluster_Randomised Trial in Zimbabwe. PLoS Medicine. 3(7) e238
Creese A, Floyd K, Alban A, Guiness L (2002) Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 359: 1635-42
Dowdy DW, Sweat MD, Holtgrave DR (2006) Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis
Gilson L, Mkanje R, Grosskurth H et al (1997) Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet; 350; 1805-9
Gray RH, Kigozi G, Serwadda D et al (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet; 369; 657-66.
Grosskurth H, Mosha F, Todd J et al (1995) Impact of improved tre4atment of sexually transmitted diseases on HIV infection in rural Tanzania: a randomised controlled trial. Lancet; 346; 530-6.
Hogan D, Baltussen R, Hayashi C et al (2005) Cost effectiveness anlaysis of strategies to combat HIV/AIDS in developing countries. BMJ, dol:10.1136/bmj.38643.368692.68
Kahn JG, Marseille E, Auvert B(2006) Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting. PLoS Medicine; 3 (12) e517.
Quigley MA, Kamali A, Kinsman J et al (2004) The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda. AIDS; 18: pp 2055-2063.
Sweat M, Kerrigan D, Moreno L(2006) Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic. J Health Communication; 11 Supp 2; 123-42
Sweat MD, O’Reilly KR, Schmid GP, et al (2004) Cost-effectiveness of nevirapine to prevent mother to child HIV transmission in eight African countries. AIDS 18 pp 1661-1671
Vickerman P, Terris-Prestholt F, Delany S et al (2006) Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sex Transm Dis 33 (10 supp) pp S122-32
Williams BG, Lloyd-Smith JO, Gouws E(2006) The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa. PLoS Medicine; 3 (7) e262
Wilkinson D, Floyd K & Gilks CF (2000) National and provincial estimated costs and cost effectiveness of a programme to reduce mother to child HIV transmission in South Africa. SAMJ 90 (8) pp 794-8.